General, N.B. Reg. 2014-27
Section 28
Formulary
Cite as General, N.B. Reg. 2014-27, s. 28 · current to November 1, 2026 · read from New Brunswick Acts and Regulations on November 16, 2026
The text
(1) A request under subsection 29(4) of the Act shall be made on a form provided by the Minister and signed by a provider or medical practitioner.
(2) For the purposes of subsection 29(4) of the Act, the information to be provided is as follows:
(a) the name, dosage form, strength and treatment schedule of the drug;
(b) whether the request is for an approval of a brand name product when a pharmaceutical equivalent or a pharmaceutical alternative is available;
(c) clinical information that outlines the request of the member of the Plan;
(d) outcome measures to support continued use and to stop treatment;
(e) supporting laboratory tests and objective clinical measures;
(f) details of previous treatment with other therapies or products, if applicable;
(g) details of availability of the drug to the member of the Plan from other sources; and
(h) supporting published data and evidence for use.
Read the General on the Province's website ↗
Made under Prescription and Catastrophic Drug Insurance Act, 2014, c.4.